PATENT CLAIM ANALYSIS

Application Number: 15780398
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "275000"]

Abstract:
The disclosure includes a method of inducing direct reprogramming (transdifferentiation) into non-oncogenic cells accompanied by tumor cell apoptosis in human tumor cells using a small molecule composition, based on the mechanism of chemical-induction of direct cellular reprogramming. The disclosure also includes a small molecule composition used for the method, and culture media and agents prepared from the composition.

Claim (Index 11):
A kit for inducing reprogramming or transdifferentiation of human tumor cells directly into non-oncogenic cells and accompanying tumor cell apoptosis, wherein the kit comprises a composition according to any one of  claims 1 - 8  or an anti-tumor drug or a medical formulation developed and manufactured based on the composition or an agent or a culture medium prepared based on the composition.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.48837
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13697274', '15376536', '13704214', '15446552', '15072769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7789829570199388
- 35 USC 102 Novelty (BERT): 0.5109911891917026
- Combined Prediction Score: 0.7521837802371152
- Mean Citation Score: 247.068706
- Max Citation Score: 257.53943
- Similarity Product: 168.09588030012011

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test